Book a Demo

Category: Partnership

Posted on

Avicenna.AI Joins Nuance AI Marketplace, Offering Cutting-Edge Solutions for Diagnostic Imaging

Avicenna.AI Joins Nuance AI Marketplace, Offering Cutting-Edge Solutions for Diagnostic Imaging

Marseille, France – 29th June, 2021 – Avicenna.AI today announced that their FDA-cleared applications for neurovascular emergencies, CINA-ICH & CINA–LVO, are available on the Nuance® AI Marketplace, the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry’s most widely used radiology reporting platform.

CINA offers radiologists an unparalleled solution for triaging patients with positive impact on high occurrence life-threatening pathologies. CINA-ICH and CINA-LVO automatically detect and prioritize acute intracranial hemorrhage and large vessel occlusion cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.

The Nuance AI Marketplace functions like an app store dedicated to radiology. It gives algorithm developers consolidated, at-scale access to users of Nuance PowerScribe™, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 9,000 connected healthcare facilities. Radiologists can discover, test, and use AI models from within their familiar Nuance PowerScribe reporting and workflow orchestration solutions to increase reporting efficiency and quality, and to help care teams improve patient outcomes and healthcare costs. A built-in feedback channel lets users share real-world results with developers for model refinement and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing AI usage, costs, and performance.

“We are glad to partner with a global partner such as Nuance who shares our same values to put patient care at the core of their business. Together we are committed to transforming medical imaging by empowering radiologists in their daily tasks. Thanks to this partnership and our combined solutions, we aim to advance the future of healthcare,” said Cyril Di Grandi, Chief Executive Officer and co-founder of Avicenna.AI.

Posted on

Arterys & Avicenna.AI Join Forces on AI Stroke Detection

Arterys & Avicenna.AI Join Forces on AI Stroke Detection

San Francisco, CA & Paris, FRANCE – December 1, 2020 – Medical imaging AI specialist Avicenna.AI today announced that its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.

Arterys has fully integrated the CINA Head AI algorithms and will make them available via its FDA-cleared MICA platform to its installed base in the coming weeks. The platform’s cloud SaaS model enables CINA Head’s workflow-enhancing algorithms to be delivered instantly to any of Arterys’ existing customers.

“Given CMS’s recent NTAP reimbursement decision regarding AI-powered LVO detection, we believe that AI is finally ready to transform clinical practice, and we’re excited to make Avicenna’s AI innovations available to doctors around the world,” said John Axerio-Cilies, Arterys co-founder and CEO. “We’ve tuned the experience for seamless workflow integration—towards the ends of efficient and effective analysis of non-contrast head CTs and CTAs and accurate detection of intracranial hemorrhages and LVO strokes.”

Using a combination of deep learning and machine learning technologies, CINA Head automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.

“Arterys’s platform is the most agile in this new internet-based era of medical AI,” said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “They help companies like us go from code-to-clinic in weeks not years, giving radiologists the ability to instantly enhance their workflows with our AI – whenever they want to.”

About Arterys

Arterys is the market leader and the world’s first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions. For more information on Arterys, please Arterys website.

Posted on

Avicenna.AI Partners With Canon Medical on AI Stroke Detection

Avicenna.AI Partners With Canon Medical on AI Stroke Detection

Paris, FRANCE – November 10, 2020 – Medical imaging AI specialist Avicenna.AI today announced a partnership with Canon Medical Systems Corporation to deliver a fully integrated stroke detection AI solution for Canon’s Automation Platform.

With this partnership, Avicenna provides Canon with its FDA-approved CINA Head triage AI solution for neurovascular emergencies, which detects two of the leading causes of stroke – intracranial hemorrhage (ICH) and large vessel occlusion (LVO) – from CT-scan imaging.

Using a combination of deep learning and machine learning technologies, CINA Head automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.

CINA’s ICH detection capability was validated using data from 814 cases conducted at more than 250 imaging centers across the United States, with 96% accuracy, 91.4% sensitivity and 97.5% specificity. The product’s LVO detection capability was validated based on 476 cases, with 97.7% accuracy 97.9% sensitivity and 97.6% specificity.

Toshiki Kato, General Manager of Healthcare IT, Canon Medical Systems, said, “Our partnership with Avicenna demonstrates our commitment to providing our customers with AI solutions that help them to improve the quality of care. With its proven ability to help radiologists to identify pathologies quickly, but also to highlight those that require the most urgent care, CINA Head is exactly the kind of innovative solution that we want to offer clinicians.”

Cyril Di Grandi, co-founder and CEO, Avicenna.AI, said, “Our partnership with a medical imaging modality leader like Canon Medical Systems is a testament to the excellent accuracy, sensitivity and specificity data that has been gathered during our validation phase. We look forward to working with our new partner to bring the benefits of our AI-powered stroke triage solution to the emergency room and beyond.”

About Canon Medical Systems Corporation
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical, we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life. For more information, visit the Canon Medical website: https://global.medical.canon.

COMPLIANCE

MY AVICENNA PLATFORM

follow us

Linkedin Youtube Twitter